Frederickson R C, Burgis V, Harrell C E, Edwards J D
Science. 1978 Mar 24;199(4335):1359-62. doi: 10.1126/science.204012.
Substance P produces analgesia when administered to mice in very small doses by the intraventricular route (1.25 to 5 nanograms per mouse). The analgesic effect can be blocked by naloxone. At higher doses (greater than 50 nanograms per mouse), this activity is lost. At these higher doses, however, substance P produced hyperalgesia when combined with naloxone and analgesia when combined with baclofen [beta-(4-chlorophenyl)-gamma-aminobutyric acid]. Substance P may have dual actions in brain, releasing endorphins at very low doses and directly exciting neuronal activity in nociceptive pathways at higher doses.
当以非常小的剂量通过脑室内途径(每只小鼠1.25至5纳克)给小鼠施用时,P物质会产生镇痛作用。这种镇痛作用可被纳洛酮阻断。在较高剂量(每只小鼠大于50纳克)时,这种活性丧失。然而,在这些较高剂量下,P物质与纳洛酮联合使用时会产生痛觉过敏,与巴氯芬[β-(4-氯苯基)-γ-氨基丁酸]联合使用时会产生镇痛作用。P物质在大脑中可能具有双重作用,在非常低的剂量下释放内啡肽,在较高剂量下直接激发伤害性感受通路中的神经元活动。